Jul 02, 2019 11:16am EDT HIV Eliminated from the Genomes of Living Animals; Excision BioTherapeutics Advancing the Innovation to Clinical Development
Nov 13, 2017 10:01am EST Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to be Used for Viral Infections
Sep 06, 2017 10:00am EDT HIV Cure-Focused Excision BioTherapeutics Secures $10 Million in Seed Funding Led by ARTIS Ventures
Mar 21, 2016 5:31pm EDT Use of CRISPR Cas9 Gene Editing Therapeutic Shown to Permanently Inactivate HIV-1 in Patient's Blood for First Time